TrialEuropean journal of nuclear medicine and molecular imaging2010

Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate.

Mattias Sandström et al.PubMed ↗Publisher ↗

No numbers read from the abstract.